Vitamin D Research
back to research menu
Toxicity
- Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model. Cancer Chemother Pharmacol. 2008 Oct;62(5):787–97.
- Risk assessment for vitamin D. American Journal of Clinical Nutrition, Vol. 85, No. 1, 6–18, January 2007. Review.
- A system for improving vitamin D nutrition in residential care. Med J Aust. 2006 Aug 21;185(4):195–8.
- Cooperative antitumor effects of vitamin D(3) derivatives and rosemary preparations in a mouse model of myeloid leukemia. Int J Cancer. 2006 Jun 15;118(12):3012–21.
- HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays. Clin Chem. 2006 Jun;52(6):1120–6.
- Phase II trial of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancer. Cancer. 2006 May 15;106(10):2136–42.
- Public health strategies to overcome barriers to optimal vitamin D status in populations with special needs. J Nutr. 2006 Apr;136(4):1135–9.
- Critique of the considerations for establishing the tolerable upper intake level for vitamin d: critical need for revision upwards. J Nutr. 2006 Apr;136(4):1117–22.
- Phase I/II study of 19-nor-1alpha-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancer. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8680–5.
- Use of alendronate in the treatment of vitamin D intoxication in infants. Turk J Pediatr. 2005 Oct–Dec;47(4):373–5.
- Pharmacokinetics and tolerability of a single dose of DN-101, a new formulation of calcitriol, in patients with cancer. Clin Cancer Res. 2005 Nov 1;11(21):7794–9.
- Responsiveness of human retinoblastoma and neuroblastoma models to a non-calcemic 19-nor Vitamin D analog. J Steroid Biochem Mol Biol. 2005 Oct;97(1–2):165–72.
- The Vitamin D requirement in health and disease. J Steroid Biochem Mol Biol. 2005 Oct;97(1–2):13–9. Review.
- High dose pulse calcitriol, docetaxel and estramustine for androgen independent prostate cancer: a phase I/II study. J Urol. 2005 Sep;174(3):888–92.
- Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Med J Aust. 2005 Jul 4;183(1):10–2.
- Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191). Steroids. 2004 Sep;69(10):629–35.
- Cholecalciferol Poisoning. Veterinary Medicine. December 2001. PDF download.
- Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr. 2001 Feb;73(2):288–94.
- Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999 May;69(5):842–56. Review.
- Serum levels of free 1,25-dihydroxyvitamin D in vitamin D toxicity. Ann Intern Med. 1995 Apr 1;122(7):511–3.
- Vitamin D and pubertal maturation. Value and tolerance of vitamin D supplementation during the winter season. Arch Pediatr. 1995 Mar;2(3):221–6. In French.
- The mechanisms of vitamin D toxicity. Bone Miner. 1990 Dec;11(3):267–72. Review.
- Vitamin D: can an upper limit be defined? J Nutr. 1989 Dec;119(12 Suppl):1825– 8. Review.
- Normal intrauterine development of the fetus of a woman receiving extraordinarily high doses of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab. 1980 Nov;51(5):1138–42.
- Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3. J Clin Invest. 1976 Jul;58(1):61–70.
back to research menu